002821.SZ Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (30 apr 2024 @ 09:04):

Stats
Dagens volum	4.02M
Gjennomsnittsvolum	5.61M
Markedsverdi	29.62B
EPS	CNY0 ( 2024-04-26 )
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	15.59
ATR14	CNY0.0530 (0.06%)

Volum Korrelasjon

Lang: -0.02 (neutral)

Kort: -0.91 (very strong negative)

Signal:(29.148) Possible Trading Opportunity Present (swing)

Asymchem Laboratories Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Asymchem Laboratories Korrelasjon - Valuta/Råvare

0.01
( neutral )

-0.44
( neutral )

0.00
( neutral )

-0.54
( weak negative )

0.68
( moderate )

Asymchem Laboratories Økonomi

Annual	2023
Omsetning:	CNY7.75B
Bruttogevinst:	CNY3.80B (49.05 %)
EPS:	CNY6.26

FY	2023
Omsetning:	CNY7.75B
Bruttogevinst:	CNY3.80B (49.05 %)
EPS:	CNY6.26

FY	2022
Omsetning:	CNY10.26B
Bruttogevinst:	CNY4.86B (47.37 %)
EPS:	CNY9.02

FY	2021
Omsetning:	CNY4.64B
Bruttogevinst:	CNY2.06B (44.33 %)
EPS:	CNY4.56

Financial Reports:

No articles found.

Asymchem Laboratories

Asymchem Laboratories (Tianjin) Co., Ltd. provides contract development and manufacturing organization services in Mainland China and internationally. The company offers drug research and development, and manufacturing services for pharmaceutical and biotech companies. Its solutions range from early clinical stage to commercial stage, including research and development, and cGMP production of advanced intermediates, active pharmaceutical ingredients, and formulations, as well as clinical research services. The company also engages in the provision of pharmaceutical analysis and testing services; sale, wholesale, and retail of drugs; and pharmaceutical science and technology development activities. The company was founded in 1999 and is headquartered in Tianjin, China.